S. Backman, V. Stambolic, and T. Mak, PTEN function in mammalian cell size regulation, Current Opinion in Neurobiology, vol.12, issue.5, pp.516-538, 2002.
DOI : 10.1016/S0959-4388(02)00354-9

S. Baker, PTEN Enters the Nuclear Age, Cell, vol.128, issue.1, pp.25-33, 2007.
DOI : 10.1016/j.cell.2006.12.023

C. Barnes, K. Ohshiro, S. Rayala, A. El-naggar, and R. Kumar, Insulin-like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer, Clinical Cancer Research, vol.13, issue.14, pp.4291-4300, 2007.
DOI : 10.1158/1078-0432.CCR-06-2040

J. Baselga, L. Norton, H. Masui, A. Pandiella, K. Coplan et al., Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal Antibodies, JNCI Journal of the National Cancer Institute, vol.85, issue.16, pp.1327-1360, 1993.
DOI : 10.1093/jnci/85.16.1327

M. Beckner, G. Gobbel, R. Abounader, F. Burovic, N. Agostino et al., Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis, Laboratory Investigation, vol.64, issue.Part 3, pp.1457-70, 2005.
DOI : 10.1016/S0006-2952(02)01456-9

R. Bei, A. Budillon, L. Masuelli, V. Cereda, D. Vitolo et al., Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients, The Journal of Pathology, vol.157, issue.3, pp.317-342, 2004.
DOI : 10.4049/jimmunol.167.11.6431

M. Belting, M. Dorrell, S. Sandgren, E. Aguilar, J. Ahamed et al., Regulation of angiogenesis by tissue factor cytoplasmic domain signaling, Nature Medicine, vol.93, issue.5
DOI : 10.1073/pnas.93.18.9764

G. Bergers and L. Benjamin, Angiogenesis: Tumorigenesis and the angiogenic switch, Nature Reviews Cancer, vol.3, issue.6, pp.401-411
DOI : 10.1038/nrc1093

C. Arteaga, Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors, Oncogene, vol.22, pp.2812-2834, 2003.

C. Birchmeier, ErbB receptors and the development of the nervous system, Experimental Cell Research, vol.315, issue.4, pp.611-619, 2009.
DOI : 10.1016/j.yexcr.2008.10.035

M. Blouin, Y. Zhao, M. Zakikhani, C. Algire, E. Piura et al., Loss of function of PTEN alters the relationship between glucose concentration and cell proliferation, increases glycolysis, and sensitizes cells to 2-deoxyglucose, Cancer Letters, vol.289, issue.2, pp.246-53, 2010.
DOI : 10.1016/j.canlet.2009.08.021

J. Zhu, H. Youssoufian, E. Rowinsky, and K. Ang, Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival, Lancet Oncol, vol.11, pp.21-29, 2010.

B. Michael, F. Andreas, and B. Daniel, Radiothérapie de la région cervico faciale : conséquences intra-orales précoces et tardives, Rev Mens Suisse Odontostomatol, vol.111, pp.69-73

S. Bouali, A. Chrétien, C. Ramacci, M. Rouyer, P. Becuwe et al., PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells, Oncol Rep, vol.21, pp.731-736

S. Bouyain, P. Longo, S. Li, K. Ferguson, and D. Leahy, The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand, Proceedings of the National Academy of Sciences, vol.273, issue.19, pp.15024-15033, 2005.
DOI : 10.1074/jbc.273.19.11667

B. Braakhuis, R. Brakenhoff, and C. Leemans, Head and neck cancer: molecular carcinogenesis, Annals of Oncology, vol.16, issue.suppl_2, pp.249-50, 2005.
DOI : 10.1093/annonc/mdi713

C. Britten, Targeting ErbB receptor signaling: a pan-ErbB approach to cancer, Mol Cancer Ther, vol.3, pp.1335-1377, 2004.

C. Bruns, M. Harbison, D. Davis, C. Portera, R. Tsan et al., Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms, Clin Cancer Res, vol.6, pp.1936-1984, 2000.

E. Bublil and Y. Yarden, The EGF receptor family: spearheading a merger of signaling and therapeutics, Current Opinion in Cell Biology, vol.19, issue.2, pp.124-158, 2007.
DOI : 10.1016/j.ceb.2007.02.008

M. Caballero, J. Grau, J. Blanch, J. Domingo-domenech, J. Auge et al., Serum Vascular Endothelial Growth Factor as a Predictive Factor in Metronomic (Weekly) Paclitaxel Treatment for Advanced Head and Neck Cancer, Archives of Otolaryngology???Head & Neck Surgery, vol.133, issue.11, pp.1143-1151, 2007.
DOI : 10.1001/archotol.133.11.1143

A. Cavalot, T. Martone, N. Roggero, G. Brondino, M. Pagano et al., Prognostic impact ofHER-2/neu expression on squamous head and neck carcinomas, Head & Neck, vol.7, issue.7, pp.655-664
DOI : 10.1007/s10006-003-0460-5

G. Cerniglia, N. Pore, J. Tsai, S. Schultz, R. Mick et al., Epidermal Growth Factor Receptor Inhibition Modulates the Microenvironment by Vascular Normalization to Improve Chemotherapy and Radiotherapy Efficacy, PLoS ONE, vol.43, issue.8, p.6539, 2009.
DOI : 10.1371/journal.pone.0006539.s003

A. Chan and P. Carter, Therapeutic antibodies for autoimmunity and inflammation, Nature Reviews Immunology, vol.10, issue.5, pp.301-317, 2010.
DOI : 10.4049/jimmunol.169.9.5171

Q. Chen, L. Samaranayake, H. Zhou, and X. L. , Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma, Oral Oncology, vol.36, issue.1, pp.95-104, 2000.
DOI : 10.1016/S1368-8375(99)00068-8

Z. Chen, P. Malhotra, G. Thomas, F. Ondrey, D. Duffey et al., Van Waes C. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer, Clin Cancer Res, vol.5, pp.1369-79, 1999.

I. Cheney, S. Neuteboom, M. Vaillancourt, M. Ramachandra, and R. Bookstein, Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes, Cancer Res, vol.59, pp.2318-2341, 1999.

F. Chergui, A. Chrétien, S. Bouali, C. Ramacci, M. Rouyer et al., Validation of a Phosphoprotein Array Assay for Characterization of Human Tyrosine Kinase Receptor Downstream Signaling in Breast Cancer, Clinical Chemistry, vol.55, issue.7, pp.1327-1363, 2009.
DOI : 10.1373/clinchem.2008.116632

J. Chung and C. Eng, Nuclear-Cytoplasmic Partitioning of Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN) Differentially Regulates the Cell Cycle and Apoptosis, Cancer Research, vol.65, issue.18, pp.8096-100, 2005.
DOI : 10.1158/0008-5472.CAN-05-1888

F. Ciardello, R. Caputo, R. Bianco, V. Damiano, G. Pomatico et al., Antitumor effects and potentiation of cytotoxic drugs activity in human cancer ceels by ZD-1839 (Iressa) and EGFRselective tyrosine kinase inhibitor, Clin canc res 6 pp, pp.2053-2063, 2000.

J. Mendelsohn and G. Tortora, Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells, Clin Cancer Res, vol.6, pp.3739-3786, 2000.

A. Citri and Y. Yarden, EGF???ERBB signalling: towards the systems level, Nature Reviews Molecular Cell Biology, vol.96, issue.7, pp.505-521, 2006.
DOI : 10.1128/MCB.14.8.5192

E. Cohen, D. Haraf, R. Kunnavakkam, K. Stenson, E. Blair et al., Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer, Journal of Clinical Oncology, vol.28, issue.20, pp.3336-3379, 2010.
DOI : 10.1200/JCO.2009.27.0397

E. Cohen, Role of Epidermal Growth Factor Receptor Pathway???Targeted Therapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck, Journal of Clinical Oncology, vol.24, issue.17, pp.2659-65, 2006.
DOI : 10.1200/JCO.2005.05.4577

C. Cripps, E. Winquist, M. Devries, D. Stys-norman, and R. Gilbert, Epidermal growth factor receptor targeted therapy in stage III and IV head and neck cancer, Current Oncology, vol.17, issue.3, pp.37-48, 2010.
DOI : 10.3747/co.v17i3.520

C. Eng, PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies, Hum Mol Genet, vol.8, pp.185-93, 1999.

J. Dawson, Z. Bu, and M. Lemmon, Ligand-Induced Structural Transitions in ErbB Receptor Extracellular Domains, Structure, vol.15, issue.8, pp.942-54, 2007.
DOI : 10.1016/j.str.2007.06.013

B. Denhart, A. Guidi, K. Tognazzi, H. Dvorak, and L. Brown, Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia, Lab Invest, vol.77, pp.659-64, 1997.

N. Dey, H. Crosswell, P. De, R. Parsons, Q. Peng et al., The Protein Phosphatase Activity of PTEN Regulates Src Family Kinases and Controls Glioma Migration, Cancer Research, vol.68, issue.6, pp.1862-71, 2008.
DOI : 10.1158/0008-5472.CAN-07-1182

D. Cristofano, A. Pandolfi, and P. , The Multiple Roles of PTEN in Tumor Suppression, Cell, vol.100, issue.4, pp.387-90, 2000.
DOI : 10.1016/S0092-8674(00)80674-1

K. Dittmann, C. Mayer, and H. Rodemann, Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity, Radiotherapy and Oncology, vol.76, issue.2, pp.157-61, 2005.
DOI : 10.1016/j.radonc.2005.06.022

K. Dittmann, C. Mayer, and H. Rodemann, Der nukle??re EGFR als neues therapeutisches Ziel. Einsichten in die nukle??re Translokation und Funktion, Strahlentherapie und Onkologie, vol.365, issue.1, pp.1-6, 2010.
DOI : 10.1016/j.bbrc.2007.11.015

G. Dong, Z. Chen, Z. Li, N. Yeh, C. Bancroft et al., Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma, Cancer Res, pp.61-5911, 2001.

S. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber et al., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature, vol.411, issue.6836, pp.494-502, 2001.
DOI : 10.1038/35078107

Z. Fan, Y. Lu, X. Wu, and J. Mendelsohn, Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells, J Biol Chem, vol.269, pp.27595-602, 1994.

Z. Fan, B. Shang, Y. Lu, J. Chou, and J. Mendelsohn, Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors

J. Fang, M. Ding, L. Yang, L. Liu, and B. Jiang, PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis, Cellular Signalling, vol.19, issue.12, pp.2487-97, 2007.
DOI : 10.1016/j.cellsig.2007.07.025

M. Favata, K. Horiuchi, E. Manos, A. Daulerio, D. Stradley et al., Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase, Journal of Biological Chemistry, vol.14, issue.29, pp.18623-18655, 1998.
DOI : 10.1074/jbc.272.27.16709

J. Ferlay, H. Shin, F. Bray, D. Forman, C. Mathers et al., Estimates of worldwide burden of cancer, Int J Cancer, vol.17, 2008.

A. Fire, S. Xu, M. Montgomery, S. Kostas, S. Driver et al., Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature, vol.48, issue.6669, pp.806-817, 1998.
DOI : 10.1016/S0091-679X(08)61399-0

J. Folkman and . Angiogenesis, Angiogenesis, Annual Review of Medicine, vol.57, issue.1, pp.1-18, 2006.
DOI : 10.1146/annurev.med.57.121304.131306

J. Folkman, Angiogenesis: an organizing principle for drug discovery?, Nature Reviews Drug Discovery, vol.57, issue.5, pp.273-86, 2007.
DOI : 10.1016/S0008-4182(05)80078-X

A. Franchi, M. Santucci, E. Masini, I. Sardi, M. Paglierani et al., Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck, Cancer, vol.86, issue.9, pp.1902-1912, 2002.
DOI : 10.1002/(SICI)1097-0215(20000501)86:3<307::AID-IJC2>3.0.CO;2-I

M. Frattini, P. Saletti, E. Romagnani, V. Martin, F. Molinari et al., PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients, British Journal of Cancer, vol.24, issue.8, pp.1139-1184, 2007.
DOI : 10.1016/j.ctrv.2003.10.003

R. Friedrich, C. Hagel, and S. Bartel-friedrich, Insulin-like growth factor-1 receptor (IGF-1R) in primary and metastatic undifferentiated carcinoma of the head and neck: a possible target of immunotherapy, Anticancer Res, vol.5, pp.1641-1644, 2010.

D. Fukumura and R. Jain, Imaging angiogenesis and the microenvironment???, APMIS, vol.7, issue.7-8, pp.695-715
DOI : 10.1016/S0008-6363(96)00063-6

D. Fukumura, F. Yuan, M. Endo, and R. Jain, Role of nitric oxide in tumor microcirculation, blood flow, vascular permeability, and leukocyte-endothelial interactions, Am J Pathol, vol.150, pp.13-25, 1997.

C. Fung and J. Grandis, Emerging drugs to treat squamous cell carcinomas of the head and neck, Expert Opinion on Emerging Drugs, vol.455, issue.7216
DOI : 10.1038/nature07385

K. Furukawa, Y. Kumon, H. Harada, S. Kohno, S. Nagato et al., PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules, International Journal of Oncology, vol.29, pp.73-81, 2006.
DOI : 10.3892/ijo.29.1.73

X. Gao, T. Neufeld, and D. Pan, Drosophila PTEN Regulates Cell Growth and Proliferation through PI3K-Dependent and -Independent Pathways, Developmental Biology, vol.221, issue.2, pp.404-422, 2000.
DOI : 10.1006/dbio.2000.9680

M. Ginn-pease and C. Eng, Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells, Cancer Res, vol.63, pp.282-288, 2003.

D. Giri and M. Ittmann, Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma, Human Pathology, vol.30, issue.4, pp.419-443, 1999.
DOI : 10.1016/S0046-8177(99)90117-X

N. Goldstein, M. Prewett, K. Zuklys, P. Rockwell, and J. Mendelsohn, Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model, Clin Cancer Res, vol.1, pp.1311-1319, 1995.

A. Goodwin, In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents, Microvascular Research, vol.74, issue.2-3, pp.172-83, 2007.
DOI : 10.1016/j.mvr.2007.05.006

J. Grandis and D. Tweardy, Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer

J. Gu, M. Tamura, R. Pankov, E. Danen, T. Takino et al., Shc and Fak Differentially Regulate Cell Motility and Directionality Modulated by Pten, The Journal of Cell Biology, vol.269, issue.2, pp.389-403, 1999.
DOI : 10.1002/cm.970250402

J. Gu, M. Tamura, and K. Yamada, Tumor Suppressor PTEN Inhibits Integrin- and Growth Factor???mediated Mitogen-activated Protein (MAP) Kinase Signaling Pathways, The Journal of Cell Biology, vol.17, issue.5, pp.1375-83, 1998.
DOI : 10.1016/0955-0674(95)80110-3

K. Guney, G. Ozbilim, A. Derin, and S. Cetin, Expression of PTEN protein in patients with laryngeal squamous cell carcinoma, Auris Nasus Larynx, vol.34, issue.4, pp.481-487, 2007.
DOI : 10.1016/j.anl.2007.03.014

R. Haddad and D. Shin, Recent Advances in Head and Neck Cancer, New England Journal of Medicine, vol.359, issue.11, pp.1143-54
DOI : 10.1056/NEJMra0707975

P. Harari and S. Huang, Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation, International Journal of Radiation Oncology*Biology*Physics, vol.49, issue.2, pp.427-460
DOI : 10.1016/S0360-3016(00)01488-7

R. Hasina, M. Whipple, L. Martin, W. Kuo, L. Ohno-machado et al., Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications, Laboratory Investigation, vol.62, issue.4
DOI : 10.1200/JCO.20.4.900

J. Gansert and J. Berlin, Lack of correlation between epidermal growth factor receptor status and response to Panitumumab monotherapy in metastatic colorectal cancer, Clin Cancer Res, vol.16, pp.2205-2218, 2010.

Y. Henderson, E. Wang, and G. Clayman, in head and neck squamous cell carcinomas, The Laryngoscope, vol.57, issue.10, pp.1553-1559, 1998.
DOI : 10.1093/nar/24.1.141

R. Herbst, M. Arquette, D. Shin, K. Dicke, E. Vokes et al., Phase II Multicenter Study of the Epidermal Growth Factor Receptor Antibody Cetuximab and Cisplatin for Recurrent and Refractory Squamous Cell Carcinoma of the Head and Neck, Journal of Clinical Oncology, vol.23, issue.24, pp.5578-87, 2005.
DOI : 10.1200/JCO.2005.07.120

T. Hideshima, L. Catley, H. Yasui, K. Ishitsuka, N. Raje et al., Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells, Blood, vol.107, issue.10, pp.4053-62, 2006.
DOI : 10.1182/blood-2005-08-3434

K. Endo, Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors, Acad Radiol, vol.14, pp.312-320, 2007.

A. Hirata, S. Ogawa, T. Kometani, T. Kuwano, S. Naito et al., ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase

R. Hitt, E. Ciruelos, M. Amador, A. Benito, J. Sanchez et al., Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy, European Journal of Cancer, vol.41, issue.3, pp.453-60, 2005.
DOI : 10.1016/j.ejca.2004.10.014

L. Hlatky, P. Hahnfeldt, and J. Folkman, Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell Us, CancerSpectrum Knowledge Environment, vol.94, issue.12, pp.883-93, 2002.
DOI : 10.1093/jnci/94.12.883

L. Hu, J. Hofmann, and R. Jaffe, Phosphatidylinostol 3-Kinase Mediates Angiogenesis and Vascular Permeability Associated with Ovarian Carcinoma, Clinical Cancer Research, vol.11, issue.22, pp.8208-8220, 2005.
DOI : 10.1158/1078-0432.CCR-05-0206

F. Huang, D. Kirkpatrick, X. Jiang, S. Gygi, and A. Sorkin, Differential Regulation of EGF Receptor Internalization and Degradation by Multiubiquitination within the Kinase Domain, Molecular Cell, vol.21, issue.6, pp.737-785, 2006.
DOI : 10.1016/j.molcel.2006.02.018

S. Huang, J. Bock, and P. Harari, Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck

S. Huang, J. Li, and P. Harari, Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade, Mol Cancer Ther, vol.7, pp.507-521, 2002.

N. Hynes and H. Lane, ERBB receptors and cancer: the complexity of targeted inhibitors, Nature Reviews Cancer, vol.7, issue.5, pp.341-54, 2005.
DOI : 10.1021/jm00130a020

A. Jacob, T. Romigh, K. Waite, and C. Eng, Nuclear PTEN levels and G2 progression in melanoma cells, Melanoma Research, vol.19, issue.4, pp.203-213, 2009.
DOI : 10.1097/CMR.0b013e32832ccd6e

R. Jain, Molecular regulation of vessel maturation, Nature Medicine, vol.4, issue.6, pp.685-93, 2003.
DOI : 10.3109/10739689709146803

M. Janmaat, F. Kruyt, J. Rodriguez, and G. Giaccone, Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways, Clin Cancer Res, vol.9, pp.2316-2342, 2003.

P. Emson and S. Moncada, Roles of nitric oxide in tumor growth, Proc Natl Acad Sci, vol.92, pp.4392-4398

M. Jhawer, S. Goel, A. Wilson, C. Montagna, Y. Ling et al., PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab, Cancer Research, vol.68, issue.6, pp.1953-61, 2008.
DOI : 10.1158/0008-5472.CAN-07-5659

M. Jhawer, S. Goel, A. Wilson, C. Montagna, Y. Ling et al., PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab, Cancer Research, vol.68, issue.6, pp.1953-61, 2008.
DOI : 10.1158/0008-5472.CAN-07-5659

B. Jiang, G. Jiang, J. Zheng, Z. Lu, T. Hunter et al., Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1, Cell Growth Differ, vol.12, pp.363-372, 2001.

A. Jimeno, B. Rubio-viqueira, M. Amador, D. Oppenheimer, N. Bouraoud et al., Epidermal Growth Factor Receptor Dynamics Influences Response to Epidermal Growth Factor Receptor Targeted Agents, Cancer Research, vol.65, issue.8, pp.3003-3013, 2005.
DOI : 10.1158/0008-5472.CAN-04-3586

N. Johnson, Tobacco use and oral cancer: a global perspective, J Dent Educ, vol.65, pp.328-367, 2001.

P. Becuwe, Damaged DNA binding protein 2 plays a role in breast cancer cell growth, PLoS One, vol.4, p.2002, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00276571

Y. Kawaguchi, K. Kono, K. Mimura, H. Sugai, H. Akaike et al., Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma, International Journal of Cancer, vol.11, issue.4, pp.781-788, 2007.
DOI : 10.1023/A:1027372409361

URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.22370/pdf

S. Kim, H. Uehara, T. Karashima, D. Shepherd, J. Killion et al., Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice, Clin Cancer Res, issue.9

S. Kim, J. Kim, J. Kim, C. Yun, E. Kim et al., Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells, Cancer Letters, vol.296, issue.2, pp.150-159, 2010.
DOI : 10.1016/j.canlet.2010.04.006

A. Kiyatkin, E. Aksamitiene, N. Markevich, N. Borisov, J. Hoek et al., Scaffolding Protein Grb2-associated Binder 1 Sustains Epidermal Growth Factor-induced Mitogenic and Survival Signaling by Multiple Positive Feedback Loops, Journal of Biological Chemistry, vol.19, issue.29, pp.19925-19963, 2006.
DOI : 10.1128/MCB.19.6.4279

L. Kotelevets, J. Van-hengel, E. Bruyneel, M. Mareel, F. Van-roy et al., Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness, The FASEB Journal, vol.19, issue.1, pp.115-122, 2005.
DOI : 10.1096/fj.04-1942fje

D. Koul, R. Parthasarathy, R. Shen, M. Davies, S. Jasser et al., Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN, Oncogene, vol.20, issue.46, pp.6669-78, 2001.
DOI : 10.1016/S0166-2236(97)01169-7

A. Kreimer, G. Clifford, P. Boyle, and S. Franceschi, Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review, Cancer Epidemiology Biomarkers & Prevention, vol.14, issue.2, pp.467-75, 2005.
DOI : 10.1158/1055-9965.EPI-04-0551

T. Kruser and D. Wheeler, Mechanisms of resistance to HER family targeting antibodies, Experimental Cell Research, vol.316, issue.7, pp.1083-100, 2010.
DOI : 10.1016/j.yexcr.2010.01.009

J. Kurai, H. Chikumi, K. Hashimoto, K. Yamaguchi, A. Yamasaki et al., Antibody-Dependent Cellular Cytotoxicity Mediated by Cetuximab against Lung Cancer Cell Lines, Clinical Cancer Research, vol.13, issue.5, pp.1552-61, 2007.
DOI : 10.1158/1078-0432.CCR-06-1726

J. Lee and M. Kim, The role of GSK3 in glucose homeostasis and the development of insulin resistance, Diabetes Research and Clinical Practice, vol.77, issue.3, pp.49-57, 2007.
DOI : 10.1016/j.diabres.2007.01.033

J. Lee, J. Soria, K. Hassan, A. El-naggar, X. Tang et al., Loss of PTEN Expression as a Prognostic Marker for Tongue Cancer, Archives of Otolaryngology???Head & Neck Surgery, vol.127, issue.12, pp.1441-1446, 2001.
DOI : 10.1001/archotol.127.12.1441

D. Li, H. Sun, and . Pten, PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells, Proceedings of the National Academy of Sciences, vol.91, issue.19, pp.15406-15417, 1998.
DOI : 10.1073/pnas.91.19.9185

J. Li, L. Simpson, M. Takahashi, C. Miliaresis, M. Myers et al., The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene, Cancer Res, vol.58, pp.5667-72, 1998.

S. Li, K. Schmitz, P. Jeffrey, J. Wiltzius, P. Kussie et al., Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell, pp.301-312, 2005.

X. Li, R. Luwor, Y. Lu, K. Liang, and Z. Fan, Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells, Oncogene, vol.25, issue.4, pp.525-560, 2006.
DOI : 10.1038/sj.onc.1209075

Y. Li, B. Zhou, J. Deng, Y. Pan, N. Hay et al., A Hypoxia-Independent Hypoxia-Inducible Factor-1 Activation Pathway Induced by Phosphatidylinositol-3 Kinase/Akt in HER2 Overexpressing Cells, Cancer Research, vol.65, issue.8, pp.3257-63, 2005.
DOI : 10.1158/0008-5472.CAN-04-1284

K. Liang, K. Ang, L. Milas, N. Hunter, and Z. Fan, The epidermal growth factor receptor mediates radioresistance, International Journal of Radiation Oncology*Biology*Physics, vol.57, issue.1, pp.246-54, 2003.
DOI : 10.1016/S0360-3016(03)00511-X

H. Liao and G. Carpenter, Cetuximab/C225-Induced Intracellular Trafficking of Epidermal Growth Factor Receptor, Cancer Research, vol.69, issue.15, pp.6179-83, 2009.
DOI : 10.1158/0008-5472.CAN-09-0049

A. Lièvre, J. Bachet, V. Boige, A. Cayre, L. Corre et al., Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab, Journal of Clinical Oncology, vol.26, issue.3, pp.374-383, 2008.
DOI : 10.1200/JCO.2007.12.5906

S. Lin, K. Makino, W. Xia, A. Matin, Y. Wen et al., Nuclear localization of EGF receptor and its potential new role as a transcription factor, Nature Cell Biology, vol.75, issue.9, pp.802-810, 2001.
DOI : 10.1016/0092-8674(93)90328-N

B. Linggi and G. Carpenter, ErbB receptors: new insights on mechanisms and biology, Trends in Cell Biology, vol.16, issue.12, pp.649-56, 2006.
DOI : 10.1016/j.tcb.2006.10.008

B. Liu, M. Fang, M. Schmidt, Y. Lu, J. Mendelsohn et al., Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity, Br J Cancer, vol.82, pp.1991-2000, 2000.

Y. Liu, J. Wu, P. Ho, L. Chen, C. Chen et al., Anti-angiogenic action of 5,5-diphenyl-2-thiohydantoin-N10 (DPTH-N10), Cancer Letters, vol.271, issue.2, pp.294-305, 2008.
DOI : 10.1016/j.canlet.2008.06.016

H. Lo, M. Ali-seyed, Y. Wu, G. Bartholomeusz, S. Hsu et al., Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin ??1 and CRM1, Journal of Cellular Biochemistry, vol.258, issue.6, pp.1570-83, 2006.
DOI : 10.1128/MCB.19.2.1210

A. López-albaitero and R. Ferris, Immune Activation by Epidermal Growth Factor Receptor???Specific Monoclonal Antibody Therapy for Head and Neck Cancer, Archives of Otolaryngology???Head & Neck Surgery, vol.133, issue.12, pp.1277-81, 2007.
DOI : 10.1001/archotol.133.12.1277

T. Lynch, T. Patel, L. Dreisbach, M. Mccleod, W. Heim et al., Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non???Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099, Journal of Clinical Oncology, vol.28, issue.6, pp.911-918, 2010.
DOI : 10.1200/JCO.2009.21.9618

T. Maehama and J. Dixon, The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate, Journal of Biological Chemistry, vol.317, issue.22, pp.13375-13383, 1998.
DOI : 10.1016/S0092-8674(00)80272-X

L. Mahimainathan, F. Das, B. Venkatesan, and G. Choudhury, Mesangial Cell Hypertrophy by High Glucose Is Mediated by Downregulation of the Tumor Suppressor PTEN, Diabetes, vol.55, issue.7, pp.2115-2140
DOI : 10.2337/db05-1326

S. Maloney, D. Sullivan, S. Suchting, J. Herbert, E. Rabai et al., Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane, British Journal of Cancer, vol.25, issue.6, pp.957-66, 2009.
DOI : 10.1158/0008-5472.CAN-07-6496

V. Papadimitrakopoulou, Akt activation correlates with adverse outcome in tongue cancer, Cancer, vol.104, pp.2430-2436, 2005.

D. Mcdonald, L. Munn, and R. Jain, Vasculogenic Mimicry: How Convincing, How Novel, and How Significant?, The American Journal of Pathology, vol.156, issue.2, pp.383-391, 2000.
DOI : 10.1016/S0002-9440(10)64740-2

M. Mencobi, F. Grillo-ruggieri, A. Salami, F. Scasso, L. Rebella et al., Induction chemotherapy in head and neck patients followed by concomitant docetaxel-based radiotherapy, Eur J Cancer Care, 2010.

L. Milas, T. Akimoto, N. Hunter, K. Mason, L. Buchmiller et al., Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas, International Journal of Radiation Oncology*Biology*Physics, vol.52, issue.2
DOI : 10.1016/S0360-3016(01)02693-1

L. Milas, Z. Fan, N. Andratschke, and K. Ang, Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies, International Journal of Radiation Oncology*Biology*Physics, vol.58, issue.3, pp.966-71, 2004.
DOI : 10.1016/j.ijrobp.2003.08.035

S. Mise-omata, Y. Obata, S. Iwase, N. Mise, and T. Doi, Transient strong reduction of PTEN expression by specific RNAi induces loss of adhesion of the cells, Biochemical and Biophysical Research Communications, vol.328, issue.4, pp.1034-1076, 2005.
DOI : 10.1016/j.bbrc.2005.01.066

R. Mishra, Glycogen synthase kinase 3 beta: can it be a target for oral cancer, Molecular Cancer, vol.9, issue.1, p.144, 2010.
DOI : 10.1186/1476-4598-9-144

S. Morgan and J. Grandis, ErbB receptors in the biology and pathology of the aerodigestive tract, Experimental Cell Research, vol.315, issue.4, pp.572-82, 2009.
DOI : 10.1016/j.yexcr.2008.08.009

N. Tonks, The lipid phosphatase activity of PTEN is critical for its tumor supressor function, Proc Natl Acad Sci, pp.13513-13521, 1998.

Y. Nagata, K. Lan, X. Zhou, M. Tan, F. Esteva et al., PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients, Cancer Cell, vol.6, issue.2, pp.117-144, 2004.
DOI : 10.1016/j.ccr.2004.06.022

J. Szöllosi, Lipid rafts and the local density of ErbB proteins influence the biological role of homoand heteroassociations of ErbB2, J Cell Sci, vol.115, pp.4251-62, 2002.

A. Niemisto, I. Shmulevich, O. Yli-harja, L. Chirieac, and S. Hamilton, Automated Quantification of Lymph Node Size and Number in Surgical Specimens of Stage II Colorectal Cancer, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference, pp.6313-6319, 2005.
DOI : 10.1109/IEMBS.2005.1615941

G. Niu, K. Wright, M. Huang, L. Song, E. Haura et al., Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis, Oncogene, vol.21, issue.13, pp.2000-2008, 2002.
DOI : 10.1074/jbc.271.16.9503

URL : http://www.nature.com/onc/journal/v21/n13/pdf/1205260a.pdf

H. Nozawa, G. Howell, S. Suzuki, Q. Zhang, Y. Qi et al., Combined Inhibition of PLC??-1 and c-Src Abrogates Epidermal Growth Factor Receptor-Mediated Head and Neck Squamous Cell Carcinoma Invasion, Clinical Cancer Research, vol.14, issue.13, pp.4336-4380, 2008.
DOI : 10.1158/1078-0432.CCR-07-4857

O. , P. Rhys-evans, P. Archer, D. Eccles, and S. , C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors, Oral Oncol, vol.38, pp.73-80, 2002.

W. Hong and H. Lee, Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma, Clin Cancer Res, vol.12, pp.653-61, 2006.

K. Okami, L. Wu, G. Riggins, P. Cairns, M. Goggins et al., Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors, Cancer Res, vol.58, pp.509-520, 1998.

S. Olivier, P. Formento, J. Fischel, M. Etienne, and G. Milano, Epidermal growth factor receptor expression and suramin cytotoxicity in vitro, European Journal of Cancer and Clinical Oncology, vol.26, issue.8, pp.867-71, 1990.
DOI : 10.1016/0277-5379(90)90186-W

J. Overholser, M. Prewett, A. Hooper, H. Waksal, and D. Hicklin, Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice, Cancer, vol.151, issue.1, pp.74-82, 2000.
DOI : 10.1016/0016-5085(92)90093-E

P. Pandolfi, Breast Cancer ??? Loss of PTEN Predicts Resistance to Treatment, New England Journal of Medicine, vol.351, issue.22, pp.2337-2345, 2004.
DOI : 10.1056/NEJMcibr043143

C. Panousis, V. Rayzman, T. Johns, C. Renner, Z. Liu et al., Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR, British Journal of Cancer, vol.38, issue.Suppl 4, pp.1069-77, 2005.
DOI : 10.1016/S1040-8428(00)00134-7

W. Pattje, E. Schuuring, M. Mastik, L. Slagter-menkema, M. Schrijvers et al., The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer, British Journal of Cancer, vol.39, issue.12, pp.1778-85, 2010.
DOI : 10.1038/onc.2008.241

W. Pattje, E. Schuuring, M. Mastik, L. Slagter-menkema, M. Schrijvers et al., The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer, British Journal of Cancer, vol.39, issue.12, pp.1778-85, 2010.
DOI : 10.1038/onc.2008.241

Y. Paulis, P. Soetekouw, H. Verheul, V. Tjan-heijnen, and A. Griffioen, Signalling pathways in vasculogenic mimicry, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1806, issue.1, pp.18-28, 1806.
DOI : 10.1016/j.bbcan.2010.01.001

T. Pawlik and K. Keyomarsi, Role of cell cycle in mediating sensitivity to radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.4, pp.928-970, 2004.
DOI : 10.1016/j.ijrobp.2004.03.005

D. Peng, Z. Fan, Y. Lu, T. Deblasio, H. Scher et al., Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145, Cancer Res, vol.56, pp.3666-3675, 1996.

L. Pignataro, M. Corsi, G. Sambataro, L. Porcaro, P. Tredici et al., Plasmatic cytokine network in patients with laryngeal carcinoma after surgical treatment, Anticancer Res, vol.21, pp.3621-3626, 2001.

N. Pore, S. Liu, D. Haas-kogan, O. Rourke, D. Maity et al., PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter, Cancer Res, vol.63, pp.236-277, 2003.

P. Pradhan-palikhe, T. Vesterinen, J. Tarkkanen, I. Leivo, T. Sorsa et al., Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer, Oral Oncology, vol.46, issue.7, pp.514-522, 2010.
DOI : 10.1016/j.oraloncology.2010.03.002

A. Psyrri, Z. Yu, P. Weinberger, C. Sasaki, B. Haffty et al., Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis, Clinical Cancer Research, vol.11, issue.16, pp.5856-62, 2005.
DOI : 10.1158/1078-0432.CCR-05-0420

J. Puc and R. Parsons, PTEN Loss Inhibits CHK1 to Cause Double Stranded-DNA Breaks in Cells, Cell Cycle, vol.4, issue.7, pp.927-936, 2005.
DOI : 10.4161/cc.4.7.1795

P. Bunn and . Jr, The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer, Clin Cancer Res, vol.11, pp.795-805, 2005.

A. Radu, V. Neubauer, T. Akagi, H. Hanafusa, and M. Georgescu, PTEN Induces Cell Cycle Arrest by Decreasing the Level and Nuclear Localization of Cyclin D1, Molecular and Cellular Biology, vol.23, issue.17, pp.6139-6188, 2003.
DOI : 10.1128/MCB.23.17.6139-6149.2003

C. Ragin, F. Modugno, and S. Gollin, The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus, Journal of Dental Research, vol.86, issue.2, pp.104-118, 2007.
DOI : 10.1146/annurev.mi.48.100194.002235

A. Ranganathan, A. Adam, and J. Aguirre-ghiso, Opposing Roles of Mitogenic and Stress Signaling Pathways in the Induction of Cancer Dormancy, Cell Cycle, vol.5, issue.16, pp.1799-807, 2006.
DOI : 10.4161/cc.5.16.3109

P. Reddy, W. Zheng, and K. Liu, Mechanisms maintaining the dormancy and survival of mammalian primordial follicles, Trends in Endocrinology & Metabolism, vol.21, issue.2, pp.96-103, 2010.
DOI : 10.1016/j.tem.2009.10.001

J. Ridge, B. Glisson, E. Horwitz, and M. Lango, Head and Neck tumors, in Cancer Management : a multidisciplinary approach, 2007.

J. Roda, T. Joshi, J. Butchar, J. Mcalees, A. Lehman et al., The Activation of Natural Killer Cell Effector Functions by Cetuximab-Coated, Epidermal Growth Factor Receptor Positive Tumor Cells is Enhanced By Cytokines, Clinical Cancer Research, vol.13, issue.21, pp.6419-6447, 2007.
DOI : 10.1158/1078-0432.CCR-07-0865

Y. Rong, V. Belozerov, C. Tucker-burden, G. Chen, D. Durden et al., Epidermal Growth Factor Receptor and PTEN Modulate Tissue Factor Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity, Cancer Research, vol.69, issue.6, pp.2540-2549
DOI : 10.1158/0008-5472.CAN-08-1547

M. Rosner, C. Fuchs, N. Siegel, A. Valli, and M. Hengstschläger, Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle, Human Molecular Genetics, vol.68, issue.6, pp.3298-310, 2009.
DOI : 10.1016/j.devcel.2006.10.007

M. Salaspuro, Alcohol consumption and cancer of the gastrointestinal tract, Best Practice & Research Clinical Gastroenterology, vol.17, issue.4, pp.679-94, 2003.
DOI : 10.1016/S1521-6918(03)00035-0

E. Sauter, M. Nesbit, J. Watson, A. Klein-szanto, S. Litwin et al., Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck, Clin Cancer Res, vol.5, pp.775-82, 1999.

S. Scanga, L. Ruel, R. Binari, B. Snow, V. Stambolic et al., The conserved PI3???K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila, Oncogene, vol.19, issue.35, pp.3971-3978, 2000.
DOI : 10.1101/gad.9.9.1087

O. Scharovsky, L. Mainetti, and R. Vr, METRONOMIC CHEMOTHERAPY. CHANGING THE PARADIGM THAT MORE IS BETTER, Current Oncology, vol.16, issue.2, pp.7-15, 2009.
DOI : 10.3747/co.v16i2.420

C. Schimanski, U. Linnemann, and M. Berger, Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver, Canc. Res, vol.59, pp.5169-5175, 1999.

T. Schneider-merck, L. Van-bueren, J. Berger, S. Rossen, K. Van-berkel et al., Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage, The Journal of Immunology, vol.184, issue.1, pp.512-532, 2010.
DOI : 10.4049/jimmunol.0900847

A. Scott, F. Lee, N. Tebbutt, R. Herbertson, S. Gill et al., A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors, Proceedings of the National Academy of Sciences, vol.61, issue.6, pp.4071-4077, 2007.
DOI : 10.1089/153685903322328947

Q. She, D. Solit, A. Basso, and M. Moasser, Resistance to gefitinib in PTEN-null HER overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling, Clin Cancer Res, vol.12, pp.4340-4346

W. Shen, A. Balajee, J. Wang, H. Wu, C. Eng et al., Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity, Cell, vol.128, issue.1, pp.157-70, 2007.
DOI : 10.1016/j.cell.2006.11.042

C. Wikstrand, D. Bigner, W. Gooding, F. Furnari, and J. Grandis, Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

J. Song and J. Grandis, STAT signaling in head and neck cancer, Oncogene, vol.19, issue.21, pp.2489-95, 2000.
DOI : 10.1002/(SICI)1097-0215(19981029)78:3<326::AID-IJC12>3.0.CO;2-4

M. Sos, M. Koker, B. Weir, S. Heynck, R. Rabinovsky et al., PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR, Cancer Research, vol.69, issue.8, pp.3256-61, 2009.
DOI : 10.1158/0008-5472.CAN-08-4055

M. Soula-rothhut, C. Coissard, H. Sartelet, C. Boudot, G. Bellon et al., The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells, Experimental Cell Research, vol.304, issue.1, pp.187-201, 2005.
DOI : 10.1016/j.yexcr.2004.10.026

D. Soulieres, N. Senzer, E. Vokes, M. Hidalgo, S. Agarwala et al., Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck, Journal of Clinical Oncology, vol.22, issue.1, pp.77-85
DOI : 10.1200/JCO.2004.06.075

J. Siderovski, D. Mak, and T. , Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN, Cell, vol.95, pp.29-39, 1998.

F. Sung, T. Poon, E. Hui, B. Ma, E. Liong et al., Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells, In Vivo, vol.19, pp.237-282, 2005.

C. Sweeney, D. Fambrough, C. Huard, A. Diamonti, E. Lander et al., Growth Factor-specific Signaling Pathway Stimulation and Gene Expression Mediated by ErbB Receptors, Journal of Biological Chemistry, vol.26, issue.25, pp.22685-98, 2001.
DOI : 10.1126/science.283.5398.83

URL : http://www.jbc.org/content/276/25/22685.full.pdf

S. Temam, H. Kawaguchi, A. El-naggar, J. Jelinek, H. Tang et al., Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer, Journal of Clinical Oncology, vol.25, issue.16, pp.2164-70, 2007.
DOI : 10.1200/JCO.2006.06.6605

N. Thomas, M. Pernot, R. Vanderesse, P. Becuwe, E. Kamarulzaman et al., Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties, Biochemical Pharmacology, vol.80, issue.2, pp.226-261, 2010.
DOI : 10.1016/j.bcp.2010.03.036

URL : https://hal.archives-ouvertes.fr/hal-00470159

T. Tian, K. Nan, S. Wang, X. Liang, C. Lu et al., PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells, Carcinogenesis, vol.90, issue.7, pp.1211-1220, 2010.
DOI : 10.1111/j.1349-7006.1999.tb00763.x

M. To, J. Perez-losada, J. Mao, and A. Balmain, Crosstalk Between Pten and Ras Signaling Pathways in Tumor Development, Cell Cycle, vol.4, issue.9, pp.1185-1193, 2005.
DOI : 10.4161/cc.4.9.2039

T. Tomita, M. Fujii, Y. Tokumaru, Y. Imanishi, M. Kanke et al., Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells, Cancer Letters, vol.156, issue.1, pp.83-91, 2000.
DOI : 10.1016/S0304-3835(00)00446-8

L. Trotman, M. Niki, Z. Dotan, J. Koutcher, D. Cristofano et al., Pten Dose Dictates Cancer Progression in the Prostate, PLoS Biology, vol.101, issue.3, p.59, 2003.
DOI : 10.1371/journal.pbio.0000059.g006

G. Tse, K. Yu, A. Chan, A. King, G. Chen et al., HER2 Expression Predicts Improved Survival in Patients with Cervical Node-Positive Head and Neck Squamous Cell Carcinoma, Otolaryngology-Head and Neck Surgery, vol.16, issue.4, pp.467-73, 2009.
DOI : 10.4161/cc.5.9.2716

S. Ueda, Y. Basaki, Y. M. Ogawa, K. Sakisaka, S. Kuwano et al., PTEN/Akt Signaling through Epidermal Growth Factor Receptor Is Prerequisite for Angiogenesis by Hepatocellular Carcinoma Cells That Is Susceptible to Inhibition by Gefitinib, Cancer Research, vol.66, issue.10, pp.5346-53, 2006.
DOI : 10.1158/0008-5472.CAN-05-3684

E. Uhlmann, M. Wong, R. Baldwin, M. Bajenaru, H. Onda et al., Astrocyte-specificTSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures, Annals of Neurology, vol.17, issue.3, pp.285-96, 2002.
DOI : 10.1016/S0887-8994(97)00036-2

D. Vallböhmer, W. Zhang, M. Gordon, D. Yang, Y. J. Press et al., Molecular Determinants of Cetuximab Efficacy, Journal of Clinical Oncology, vol.23, issue.15, pp.3536-3580, 2005.
DOI : 10.1200/JCO.2005.09.100

J. Vermorken, R. Mesia, F. Rivera, E. Remenar, A. Kawecki et al., Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer, New England Journal of Medicine, vol.359, issue.11, pp.1116-1143, 2008.
DOI : 10.1056/NEJMoa0802656

A. Viloria-petit, J. Rak, M. Hung, P. Rockwell, N. Goldstein et al., Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors, Am J Pathol, vol.151, pp.1523-1553, 1997.

K. Bachman, Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells, Cancer Res, vol.69, pp.8275-83, 2009.

S. Walenta, A. Salameh, H. Lyng, J. Evensen, M. Mitze et al., Correlation of high lactate levels in head and neck tumors with incidence of metastasis, Am J Pathol, vol.150, pp.409-424, 1997.

A. Weber, L. Langhanki, F. Sommerer, A. Markwarth, C. Wittekind et al., Mutations of the BRAF gene in squamous cell carcinoma of the head and neck, Oncogene, vol.22, issue.30, pp.4757-4766, 2003.
DOI : 10.1002/(SICI)1097-0142(19980715)83:2<204::AID-CNCR2>3.0.CO;2-Q

S. Wen, J. Stolarov, M. Myers, J. Su, M. Wigler et al., PTEN controls tumorinduced angiogenesis, Proc Natl Acad Sci, pp.4622-4629, 2001.
DOI : 10.1073/pnas.081063798

URL : http://www.pnas.org/content/98/8/4622.full.pdf

L. Weng, J. Brown, and C. Eng, PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways, Human Molecular Genetics, vol.10, issue.3, pp.237-279, 2001.
DOI : 10.1093/hmg/10.3.237

URL : https://academic.oup.com/hmg/article-pdf/10/3/237/9464146/dde021.pdf

L. Weng, W. Smith, J. Brown, and C. Eng, PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model, Human Molecular Genetics, vol.10, issue.6, pp.605-621, 2001.
DOI : 10.1093/hmg/10.6.605

D. Whiteman, X. Zhou, M. Cummings, S. Pavey, N. Hayward et al., Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma, International Journal of Cancer, vol.61, issue.1, pp.63-70, 2002.
DOI : 10.1054/bjoc.2000.1660

H. Wu, V. Goel, and F. Haluska, PTEN signaling pathways in melanoma, Oncogene, vol.22, issue.20, pp.3113-3135
DOI : 10.1016/S0002-9440(10)64627-5

X. Wu, Z. Fan, H. Masui, N. Rosen, and J. Mendelsohn, Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin., Journal of Clinical Investigation, vol.95, issue.4, pp.1897-905, 1995.
DOI : 10.1172/JCI117871

T. Yamatodani, L. Ekblad, E. Kjellén, A. Johnsson, H. Mineta et al., Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines, Journal of Cancer Research and Clinical Oncology, vol.30, issue.suppl 4, pp.395-402, 2009.
DOI : 10.1016/0360-3016(94)90523-1

Y. Yarden and M. Sliwkowski, Untangling the ErbB signalling network, Nature Reviews Molecular Cell Biology, vol.95, issue.2, pp.127-164, 2001.
DOI : 10.1016/0304-3835(95)03866-U

J. Yeh, E. Routh, T. Rubinas, J. Peacock, T. Martin et al., KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer, Molecular Cancer Therapeutics, vol.8, issue.4, pp.834-877, 2009.
DOI : 10.1158/1535-7163.MCT-08-0972

Z. Yu, P. Weinberger, C. Sasaki, B. Egleston, W. Speier et al., Phosphorylation of Akt (Ser473) Predicts Poor Clinical Outcome in Oropharyngeal Squamous Cell Cancer, Cancer Epidemiology Biomarkers & Prevention, vol.16, issue.3, pp.553-561, 2007.
DOI : 10.1158/1055-9965.EPI-06-0121

X. Zhang, J. Gureasko, K. Shen, P. Cole, and J. Kuriyan, An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor, Cell, vol.125, issue.6, pp.1137-1186, 2006.
DOI : 10.1016/j.cell.2006.05.013

H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan et al., Modulation of hypoxia-inducible factor-1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics, Cancer Res, vol.60, pp.1541-1546, 2000.

R. Johnson, A. Jefferson, D. Stokoe, and A. Giaccia, Loss of PTEN facilitates HIF-1-mediated gene expression, Genes Dev, vol.14, pp.391-397, 2000.